Longlong Gong
Wuxi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Case Report: Individualized circulating tumor DNA monitoring guides olaparib adjuvant therapy: an early-stage breast cancer case with somatic BRCA2 mutation.
Journal: Frontiers in oncology
Published: August 04, 2025
An integrated pathway mutation and clinical model predicts survival in unresectable HCC with hepatic arterial infusion chemotherapy combined with lenvatinib and tislelizumab.
Journal: BMC cancer
Published: September 27, 2024
Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration.
Journal: Human vaccines & immunotherapeutics
Published: July 05, 2024
Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 19, 2024
The activity and immune dynamics of PD-1 inhibition on high-risk pulmonary ground glass opacity lesions: insights from a single-arm, phase II trial.
Journal: Signal transduction and targeted therapy
Published: November 24, 2023
Biomarkers of Pathologic Complete Response to Neoadjuvant Immunotherapy in Mismatch Repair-Deficient Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 26, 2023
Identification of gene variation feature for targeted therapy of non-small cell lung cancer through combined method of DNA and RNA sequencing.
Journal: Discover oncology
Published: July 10, 2023
The characteristics and clinical relevance of tumor fusion burden in non-EBV (+) gastric cancer with MSS.
Journal: BMC gastroenterology
Published: June 15, 2022
LMO7-ALK Fusion in a Lung Adenocarcinoma Patient With Crizotinib: A Case Report.
Journal: Frontiers in oncology
Published: December 22, 2021
Comprehensive landscape and interference of clonal haematopoiesis mutations for liquid biopsy: A Chinese pan-cancer cohort.
Journal: Journal of cellular and molecular medicine
Published: April 24, 2021
Last Updated: 09/26/2026